RESULTS OF COMBINATION TREATMENT IN REPRODUCTIVE-AGED PATIENTS WITH HYSTEROMYOMA ACCOMPANIED BY MENORRHAGIAS
- Authors: Revazova Z.V.1, Adamyan L.V.1,2, Kozachenko A.V.1
-
Affiliations:
- Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia
- Moscow State Medical and Dental University
- Issue: No 9 (2016)
- Pages: 94-100
- Section: Articles
- URL: https://journals.eco-vector.com/0300-9092/article/view/247789
- ID: 247789
Cite item
Abstract
Full Text
About the authors
Zarina V. Revazova
Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia
Email: atias@bk.ru
graduate student Moscow 117997, Ac. Oparina str. 4, Russia
Leila V. Adamyan
Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia; Moscow State Medical and Dental University
Email: adamyanleila@gmail.com
member of RAS, Doctor of Medicine, Professor, Deputy Director for Science; Honored Scientist of Russia; main specialist in obstetrics and gynecology of the Ministry of Health of Russia; Head of the Department of Reproductive Medicine and Surgery, Faculty of Postgraduate Education Moscow 117997, Ac. Oparina str. 4, Russia
Andrey V. Kozachenko
Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia
Email: a_kozachenko@oparina4.ru
MD, leading researcher Moscow 117997, Ac. Oparina str. 4, Russia
References
- Адамян Л.В., ред. Миома матки: диагностика, лечение и реабилитация. Клинические рекомендации по ведению больных. М.; 2015
- Wallach E.E., Vlahos N.F. Uterine myomas: an overview of development, clinical features, and management. Obstet. Gynecol. 2004; 104(2): 393-406. doi: 10.1097/01.AOG.0000136079.62513.39.
- Maruo T., Ohara N., Wang J., Matduo H. Sex steroidal regulation of uterine leiomyoma growth and apoptosis. Hum. Reprod. Update. 2004; 10(3): 207-20. doi: 10.1093/humupd/dmh019.
- Mettler L., Schollmeyer T., Tinelli A., Malvasi A., Alkatout I. Complications of uterine fibroids and their management, surgical management of fibroids, laparoscopy and hysteroscopy versus hysterectomy, haemorrhage, adhesions, and complications. Obstet. Gynecol. Int. 2012; 2012: 791248. doi: 10.1155/2012/791248.
- Fonseca-Moutinho J.A., Barbosa L.S., Torres D.G., Nunes S.M. Abnormal uterine bleeding as a presenting symptom is related to multiple uterine leiomyoma: an ultrasound-based study. Int. J. Women’s Health. 2013; 5: 689-94. doi: 10.2147/ IJWH.S50786.
- Tsiligianis S.E., Zaitseva M., Coombs P., Shekleton P., Olshansky M., Hickey M. et al. Fibroid-associated heavy menstrual bleeding: correlation between clinical features, Doppler ultrasound assessment of vasculature, and tissue gene expression profiles. Reprod. Sci. 2012; 20(4): 361-70. doi: 10.1177/1933719112459233.
- Stewart E.A., Nowak R.A. Leiomyoma-related bleeding: a classic hypothesis updated for the molecular era. Hum. Reprod. Update. 1996; 2(4): 295-306.
- Lockwood Ch.J. Mechanisms of normal and abnormal endometrial bleeding. Menopause. 2011; 18(4): 408-11. doi: 10/1097/GME.0b013e31820bf288.
- David-Montefiore E., Rouzier R., Chapron C., Darai E. Surgical routes and complications of hysterectomy for benign disorders: a prospective observational study in French university hospitals. Hum. Reprod. 2007; 22(1): 260-5. doi: 10.1093/ humrep/del336.
- Islam M.S., Protic O., Giannubilo S.R., Toti P., Tranquilli A.L., Petraglia F. et al. Uterine leiomyoma: available medical treatments and new possible therapeutic options. J. Clin. Endocrinol. Metab. 2013; 98(3): 921-34. doi: 10.1210/ jc.2012-3237.
- Adamson G.D. Treatment of uterine fibroids: current findings with gonadotropin-releasing hormone agonists. Am. J. Obstet. Gynecol. 1992; 166(2): 746-51. doi: 10.1016/0002-9378(92)91707-H.
- Lethaby A., Vollenhoven B., Sowter M. Efficacy of pre-operative gonadotrophin hormone releasing analogues for women with uterine fibroids undergoing hysterectomy or myomectomy: a systematic review. BJOG. 2002; 109(10): 1097-108. doi: 10.1111/j.1471-0528.2002.01225.x.
- Parker W.H. Etiology, symptomatology, and diagnosis of uterine myomas. Fertil. Steril. 2007; 87(4): 725-36. doi: 10.1016/j.fertnstert.2007.01.093.
- Donnez J., Tatarchuk T.F., Bouchard P., Puscasiu L., Zakharenko N.F., Ivanova T. et al.; PEARL I Study Group. Ulipristal acetate versus placebo for fibroid treatment before surgery. N. Engl. J. Med. 2012; 366(5): 409-20. doi: 10.1056/ NEJMoa1103182.
- Donnez J., Tomaszewski J., Vazquez F., Bouchard P., Lemieszczuk B., Baro F. et al.; PEARL II Study Group. Ulipristal acetate versus leuprolide acetate for uterine fibroids. N. Engl. J. Med. 2012; 366(5): 421-32. doi: 10.1056/NEJMoa1103180.
- Munro M.G., Critchley H.O., Fraser I.S. The FIGO systems for nomenclature and classification of causes of abnormal uterine bleeding in the reproductive years: who needs them? Am. J. Obstet. Gynecol. 2012; 207(4): 259-65. doi: 10.1016/j. ajog.2012.01.046.
- Barlow D.H., Lumsden M.A., Fauser B.C., Terrill P., Bestel E. Individualized vaginal bleeding experience of women with uterine fibroids in the PEARL I randomized controlled trial comparing the effects of ulipristal acetate or placebo. Hum. Reprod. 2014; 29(3): 480-9. doi: 10.1093/humrep/det467.